Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308366970> ?p ?o ?g. }
- W4308366970 endingPage "103866" @default.
- W4308366970 startingPage "103866" @default.
- W4308366970 abstract "This review examined patterns of systemic anticancer treatment in patients with HR+ /HER2- metastatic breast cancer in real-world clinical practice in Europe since 2016 to assess whether they reflect clinical guidelines and recent changes in available treatment options. We identified 30 publications for inclusion. In studies evaluating patients up to the end of 2017, endocrine therapy predominated, with endocrine monotherapy typically used in 45-65 % of patients. More recent studies suggested that use of cyclin-dependent kinase 4/6 inhibitor therapy has gained ground since European approval in late 2016, with two studies reporting first-line use in over 55 % of patients. Chemotherapy was typically used first line in 25-45 % of patients, although current guidelines recommend endocrine therapy in the absence of a visceral crisis. In conclusion, our review suggests that the most recent treatment developments for patients with HR+ /HER2 - metastatic breast cancer are being reflected in the changing treatment patterns seen in real-world practice." @default.
- W4308366970 created "2022-11-11" @default.
- W4308366970 creator A5034058277 @default.
- W4308366970 creator A5063190142 @default.
- W4308366970 creator A5071102243 @default.
- W4308366970 creator A5084337544 @default.
- W4308366970 date "2022-12-01" @default.
- W4308366970 modified "2023-10-15" @default.
- W4308366970 title "Systemic treatment for hormone receptor-positive/HER2-negative advanced/metastatic breast cancer: A review of European real-world evidence studies" @default.
- W4308366970 cites W2144790402 @default.
- W4308366970 cites W2290950904 @default.
- W4308366970 cites W2552099557 @default.
- W4308366970 cites W2578452958 @default.
- W4308366970 cites W2588580720 @default.
- W4308366970 cites W2623534991 @default.
- W4308366970 cites W2624405581 @default.
- W4308366970 cites W2734686666 @default.
- W4308366970 cites W2763217861 @default.
- W4308366970 cites W2763988960 @default.
- W4308366970 cites W2765167427 @default.
- W4308366970 cites W2781844803 @default.
- W4308366970 cites W2796824128 @default.
- W4308366970 cites W2884798230 @default.
- W4308366970 cites W2891508609 @default.
- W4308366970 cites W2896846857 @default.
- W4308366970 cites W2898492014 @default.
- W4308366970 cites W2905011561 @default.
- W4308366970 cites W2910594252 @default.
- W4308366970 cites W2920124802 @default.
- W4308366970 cites W2944078777 @default.
- W4308366970 cites W2944402875 @default.
- W4308366970 cites W2944603650 @default.
- W4308366970 cites W2945564879 @default.
- W4308366970 cites W2947544167 @default.
- W4308366970 cites W2963501687 @default.
- W4308366970 cites W2964243716 @default.
- W4308366970 cites W2995593755 @default.
- W4308366970 cites W3006164540 @default.
- W4308366970 cites W3028279597 @default.
- W4308366970 cites W3030566389 @default.
- W4308366970 cites W3043082495 @default.
- W4308366970 cites W3049324184 @default.
- W4308366970 cites W3081949673 @default.
- W4308366970 cites W3082552926 @default.
- W4308366970 cites W3088548306 @default.
- W4308366970 cites W3088603564 @default.
- W4308366970 cites W3089070507 @default.
- W4308366970 cites W3091902443 @default.
- W4308366970 cites W3103014577 @default.
- W4308366970 cites W3109453522 @default.
- W4308366970 cites W3119511108 @default.
- W4308366970 cites W3133584322 @default.
- W4308366970 cites W3134914296 @default.
- W4308366970 cites W3137517441 @default.
- W4308366970 cites W3154226934 @default.
- W4308366970 cites W3164115667 @default.
- W4308366970 cites W3164578047 @default.
- W4308366970 cites W3166469445 @default.
- W4308366970 cites W3175652738 @default.
- W4308366970 cites W3198586584 @default.
- W4308366970 cites W3200667602 @default.
- W4308366970 cites W3207557929 @default.
- W4308366970 cites W4206571747 @default.
- W4308366970 cites W4206666777 @default.
- W4308366970 cites W4213275140 @default.
- W4308366970 cites W4293083647 @default.
- W4308366970 cites W4293771020 @default.
- W4308366970 cites W4319290974 @default.
- W4308366970 doi "https://doi.org/10.1016/j.critrevonc.2022.103866" @default.
- W4308366970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36336168" @default.
- W4308366970 hasPublicationYear "2022" @default.
- W4308366970 type Work @default.
- W4308366970 citedByCount "1" @default.
- W4308366970 countsByYear W43083669702023 @default.
- W4308366970 crossrefType "journal-article" @default.
- W4308366970 hasAuthorship W4308366970A5034058277 @default.
- W4308366970 hasAuthorship W4308366970A5063190142 @default.
- W4308366970 hasAuthorship W4308366970A5071102243 @default.
- W4308366970 hasAuthorship W4308366970A5084337544 @default.
- W4308366970 hasConcept C121608353 @default.
- W4308366970 hasConcept C126322002 @default.
- W4308366970 hasConcept C143998085 @default.
- W4308366970 hasConcept C185926286 @default.
- W4308366970 hasConcept C2775930923 @default.
- W4308366970 hasConcept C2776694085 @default.
- W4308366970 hasConcept C46699223 @default.
- W4308366970 hasConcept C530470458 @default.
- W4308366970 hasConcept C71315377 @default.
- W4308366970 hasConcept C71924100 @default.
- W4308366970 hasConceptScore W4308366970C121608353 @default.
- W4308366970 hasConceptScore W4308366970C126322002 @default.
- W4308366970 hasConceptScore W4308366970C143998085 @default.
- W4308366970 hasConceptScore W4308366970C185926286 @default.
- W4308366970 hasConceptScore W4308366970C2775930923 @default.
- W4308366970 hasConceptScore W4308366970C2776694085 @default.
- W4308366970 hasConceptScore W4308366970C46699223 @default.
- W4308366970 hasConceptScore W4308366970C530470458 @default.
- W4308366970 hasConceptScore W4308366970C71315377 @default.